New drug duo aims to stop aggressive cervical cancer from coming back
Disease control
Not yet recruiting
This study is testing if adding two drugs, pembrolizumab and lenvatinib, after standard chemoradiation and brachytherapy can better control high-risk, locally advanced cervical cancer and prevent it from returning. It will involve about 87 adults with specific high-risk forms of …
Phase: PHASE2 • Sponsor: Prof. Dr. Remi A. Nout • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC